Managing diabetic foot ulcers: economic consequences in the USA

Authors: O′Brien, Judith; Ward, Alex; Salas, Maribel

Source: Expert Review of Pharmacoeconomics and Outcomes Research, Volume 3, Number 1, February 2003 , pp. 25-32(8)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

In the USA, 11 million people are currently diagnosed with diabetes – poor glycemic control increases their risk of developing diabetes-related complications. Foot ulcers are one of the more common complications and patients developing foot ulcers are at a higher risk of having a lower extremity amputation. The majority of foot ulcers are managed in an outpatient setting, but hospitalization accounts for approximately three quarters of the total expenditures on medical care related to diabetic foot ulcers. A series of initiatives from the US government and healthcare providers aim to improve the management of diabetes, but more research is needed to establish which reduce the prevalence of foot ulcers and to establish the most cost-effective approach.

Keywords: amputation; diabetes; economics; foot ulcer; pharmacoeconomics

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14737167.3.1.25

Publication date: 2003-02-01

More about this publication?

Expert Review of Pharmacoeconomics & Outcomes Research provides expert commentary on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
Free Trials
ingentaconnect is not responsible for the content or availability of external websites